Evans John M.insider trades
In SEC Form 4 filings, Evans John M. is listed as CEO of Beam Therapeutics Inc. (BEAM). In the last 90 days, Evans John M. sold $1.19M of Beam Therapeutics Inc. (BEAM) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BEAMBeam Therapeutics Inc. | CEO | 6 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-16
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BEAMBeam Therapeutics Inc. | Oct 16 | Oct 16 | M | 25,000 | $1.03 | $25,750 | 1,072,205 | Yes | Form 4 |
| BEAMBeam Therapeutics Inc. | Oct 16 | Oct 16 | S | 25,000 | $23.98 | Sale −$599,595 | 1,047,205 | Yes | Form 4 |
| BEAMBeam Therapeutics Inc. | Oct 16 | Oct 16 | M · derivative | 25,000 | $1.03 | $25,750 | 155,804 | Yes | Form 4 |
| BEAMBeam Therapeutics Inc. | Oct 15 | Oct 16 | M | 25,000 | $1.03 | $25,750 | 1,072,205 | Yes | Form 4 |
| BEAMBeam Therapeutics Inc. | Oct 15 | Oct 16 | S | 25,000 | $23.57 | Sale −$589,150 | 1,047,205 | Yes | Form 4 |
| BEAMBeam Therapeutics Inc. | Oct 15 | Oct 16 | M · derivative | 25,000 | $1.03 | $25,750 | 180,804 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.